Everolimus
NDC 70377-090 · Biocon Pharma Inc.
Generic nameEverolimus
Dosage formTABLET, FOR SUSPENSION
RouteORAL
Active ingredient(s)EVEROLIMUS
Strength2 mg/1
Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
Marketing categoryANDA
Packages
70377-090-11 — 28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-090-11)
70377-090-23 — 4 BLISTER PACK in 1 CARTON (70377-090-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
67877-719 — Everolimus, 67877-720 — Everolimus, 67877-721 — Everolimus, 70377-010 — everolimus, 70377-011 — everolimus, 70377-012 — everolimus, 70377-013 — everolimus, 70377-069 — Everolimus, 70377-070 — EVEROLIMUS, 70377-071 — everolimus, 70377-091 — Everolimus, 70377-092 — Everolimus, 70377-112 — everolimus, 72603-254 — everolimus, 72603-255 — everolimus, 72603-256 — everolimus, 72603-257 — everolimus, 82249-610 — Everolimus, 82249-611 — Everolimus, 82249-612 — Everolimus, +63 more